Stimuli‐responsive nanoparticles for the codelivery of chemotherapeutic agents doxorubicin and siPD‐L1 to enhance the antitumor effect-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stimuli‐responsive nanoparticles for the codelivery of chemotherapeutic agents doxorubicin and siPD‐L1 to enhance the antitumor effect

Published:2020-05 Issue:4 Volume:108 Page:1710-1724
ISSN:1552-4973
Container-title:Journal of Biomedical Materials Research Part B: Applied Biomaterials
language:en
Short-container-title:J Biomed Mater Res

Author:

Zhou Ye‐juan¹,Wan Wen‐jun¹,Tong Yao¹,Chen Meng‐tian¹,Wang Dan‐dan¹,Wang Yu¹,You Ben‐gang¹,Liu Yang¹,Zhang Xue‐nong¹^ORCID

Affiliation:

1. Department of PharmaceuticsCollege of Pharmaceutical Sciences, Soochow University Suzhou People's Republic of China

Funder

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Wiley

Subject

Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm.b.34516

Reference47 articles.

1. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

2. RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?

3. A surface charge-switchable and folate modified system for co-delivery of proapoptosis peptide and p53 plasmid in cancer therapy

4. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities

5. Therapeutic Nanoparticles for Drug Delivery in Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade;Advanced Drug Delivery Reviews;2024-06

2. Peptide-Modified Cyclodextrin-Based Nanosystem for Co-Delivery of Celastrol and siPD-L1 to Tumors;ACS Applied Nano Materials;2024-05-08

3. Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system;Cancer Drug Resistance;2023

4. Drug Delivery Systems with a “Tumor-Triggered” Targeting or Intracellular Drug Release Property Based on DePEGylation;Materials;2022-07-31

5. Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology;Royal Society Open Science;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3